Dawn M. Cleaver

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the<scp>J</scp>anus kinase inhibitor oclacitinib (<scp>A</scp>poquel^®) in client‐owned dogs with atopic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 140 citations · Full text

Medicine, Dermatology, Pharmacology +11

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 130 citations · Full text

Medicine, Pharmacology, Veterinary Dermatology +14

Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life

Sallie B. Cosgrove, Dawn M. Cleaver, Vickie L. King et al. · Veterinary Dermatology · 2015 · 99 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

Margaret E. Gruen, Jamie A. E. Myers, Jezaniah‐Kira Tena et al. · Journal of Veterinary Internal Medicine · 2021 · 49 citations · Full text

Veterinary Medicine, Veterinary Clinical Sciences, Veterinary Pharmacology +17

A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody

Gina Μ. Michels, Nicole A. Honsberger, Rodney R. Walters et al. · Veterinary Anaesthesia and Analgesia · 2023 · 30 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16